NRF2 Is One of the Players Involved in Bone Marrow Mediated Drug Resistance in Multiple Myeloma

International Journal of Molecular Sciences - Switzerland
doi 10.3390/ijms19113503
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Bone Marrow Angiogenesis in Multiple Myeloma

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2005English

Multiple Myeloma Exploits Jagged1 and Jagged2 to Promote Intrinsic and Bone Marrow-Dependent Drug Resistance

Haematologica
Hematology
2019English

Old and Young Actors Playing Novel Roles in the Drama of Multiple Myeloma Bone Marrow Microenvironment Dependent Drug Resistance

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2018English

Different Presentation of Multiple Myeloma in Bone Marrow Aspiration

Journal of Cancer Science and Clinical Therapeutics
2018English

Ficolled Bone Marrow Is Superior to Bone Marrow Buffy Coat for Detection of Minimal Residual Disease in Multiple Myeloma

Hematology
Hematology
2019English

Combined Evaluation of Bone Marrow Aspirate and Biopsy Is Superior in the Prognosis of Multiple Myeloma

Diagnostic Pathology
Forensic MedicineMedicinePathologyHistology
2010English

Mesenchymal Stem Cells From Bone Marrow Regulate Invasion and Drug Resistance of Multiple Myeloma Cells by Secreting Chemokine CXCL13

Bosnian Journal of Basic Medical Sciences
Medicine
2019English

Effect of Thalidomide Therapy on Bone Marrow Angiogenesis in Multiple Myeloma

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2004English

C-Myc Deregulation Is Involved in Melphalan Resistance of Multiple Myeloma: Role of PDGF-BB

International Journal of Immunopathology and Pharmacology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy